ScannerMarket pulse
Live
A composite read across price action, options flow, sector context, institutional posture, relative strength, sentiment, and quality.
Plain-English read on Sun Pharmaceutical (SUNPHARMA) — what the signals are saying, what the risks are, and what to watch into the next session.
Directional bias, suggested option strategy, and entry / invalidation zones for Sun Pharmaceutical — derived from the convergence read above. Coming soon.
Daily foreign + domestic institutional flow into NSE-traded equities. T-1 reporting basis.
Market-wide position limit. >95% triggers F&O ban (square-off only).